Restrepo Dalilah MD entered the industry of Infectious Disease Specialists in 1993 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Infectious Disease Specialists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Infectious Disease Specialists. The business provides service to the B2C market.
To acquire more information, please contact Dalilah Restrepo Full Name Report by calling (212) 582-5006 Full Phone Report during business hours. You can also write to the business’ Single Location at 30 West 60th St Apartment An, New York City, New York NY 10023. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
|Company:||Restrepo Dalilah MD|
|Representative:||Dalilah Restrepo Full Name Report|
|Place of Business:||30 West 60th St Apartment An, New York City, NY 10023|
|Contact Number:||(212) 582-5006 Full Phone Report|
|Type of Service:||Infectious Disease Specialists|
|Market Type:||B2C (Business to Consumer)|
|Income/Year:||$500.000 to $999.999|
|Laborers:||1 to 4|
|Share This Company:|
Restrepo Dalilah MD is a company operating from New York, New York providing professional Infectious Disease Specialists and relevant B2C variables. It was founded in 1993 and registered with the SIC code 8011 as Infectious Disease Specialists, and with the NAICS code 6211110 as Infectious Disease Specialists.
With a current employee count of 1 to 4, Restrepo Dalilah MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Dalilah Restrepo Full Name Report at (212) 582-5006 Full Phone Report for related queries, or to locate its Single Location using the coordinates 40.769181,-73.982819.
The Single Location can also be found at the street address 30 West 60th St Apartment An in New York City, New York 10023 and can be engaged online through the company website at , the company Twitter , and Facebook page .